We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Disrupted Genetic Systems Discovered in Autistic Brain

By LabMedica International staff writers
Posted on 17 May 2012
By investigating gene collections rather than individual genes, researchers have now identified specific functional systems with genetic disruptions in the autistic brain.

Autism, the severe state resulting from multiple neurodevelopmental disorders named autism spectrum disorders (ASDs), is known to have a strong genetic basis. More...
However, efforts to identify the responsible genes have so far had mixed results due to the influence of many different genes as well as that different genes are involved in different autistic individuals. Scientists at the Hebrew University of Jerusalem (HUJ; Jerusalem, Israel) chose to examine groups of genes to identify and better understand multiple pathways involved in ASDs.

The study, published in the journal PLoS Genetics in March 2012, showed that the different genes involved in autism tend to be involved in specific brain processes. This can explain similarities in the behavioral symptoms of different autistics as well as the large spectrum of behaviors observed in different autistic individuals.

The main goal of the project, conducted by Dr. Sagiv Shifman and his doctoral student Eyal Ben-David at the HUJ Department of Genetics, was to test the contribution of rare genetic mutations as well as genetic variations common in the population, and to see whether these different types of genetic risk factors are related. To that end, the scientists used the Allen Brain Atlas RNA microarray dataset to construct a robust network of the human brain transcriptome based on the expression pattern of genes across different brain areas. This allowed them to discover groups of genes with shared function in the brain. Next, based on genetic data from thousands of families with autistic children, the researchers studied the contribution of different groups of genes to autism.

To their surprise, they found -- when looking at mutations found in autism as well as thousands of common gene variants that are more frequently seen in autistics -- that these mutations and variations are located in specific functional groups, that the genetic risk factors were enriched in specific groups of connected genes. When looking at families with one autistic individual (sporadic cases), and in families where there is more than one affected individual (multiplex cases), the same variants were seen acting in both cases. These groups of genes are highly active in the first year of life, and the strongest enriched of risk factors corresponded to a group of genes involved in processes of learning, memory, and sensory perception.

Shifman and Ben-David believe their work could help pave the way for development of genetic scans for early diagnosis of autism, and, by concentrating on specific gene groups, for the design of effective therapeutic drugs that could alleviate symptoms in autistics with different genetic backgrounds.

Related Links:

Hebrew University of Jerusalem



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
DNA Extraction Kit
MagMAX DNA Multi-Sample Ultra 2.0 Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.